08:00 , Mar 8, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Clostridium Clostridium botulinum toxin type A; botulinum neurotoxin type A1 nontoxic-nonhemagglutinin component (ntnH) Structural and in vitro studies suggest inhibiting binding between C. botulinum...
08:00 , Mar 8, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Autoimmune Disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Autoimmune disease Autoimmune disease Indoleamine 2, 3-dioxygenase (INDO; IDO) Mouse studies suggest IDO could help treat and prevent autoimmune diseases. In lupus-prone mice, an IDO inhibitor...